Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: In healthy subjects, the incretin effect during an oral glucose tolerance test increases with the size of glucose load, resulting in similar glucose excursions independently of the glucose loads. Whether patients with type 2 diabetes mellitus (T2DM) are able to regulate their incretin effect is unknown. RESEARCH DESIGN AND METHODS: Incretin effect was measured over 6 d by means of three 4-h oral glucose tolerance test with increasing glucose loads (25, 75, and 125 g) and three corresponding isoglycemic iv glucose infusions in eight patients with T2DM [fasting plasma glucose, mean 7.7 (range 7.0-8.9) mM; glycosylated hemoglobin, 7.0% (6.2-8.4%)] and eight matched healthy control subjects [fasting plasma glucose, 5.3 (4.8-5.7) mM; glycosylated hemoglobin, 5.4% (5.0-5.7%)]. RESULTS: Patients with T2DM exhibited higher peak plasma glucose in response to increasing oral glucose loads, whereas no differences in peak plasma glucose values among control subjects were observed. The incretin effect was significantly (P < 0.003) lower in patients with T2DM (0 ± 7, 11 ± 9, and 36 ± 5%) as compared with control subjects (36 ± 5, 53 ± 6, and 65 ± 6%). Equal and progressively delayed gastric emptying due to the increasing loads was found in both groups. Incretin hormone responses were similar. CONCLUSIONS: Up-regulation of the incretin effect in response to increasing oral glucose loads seems to be crucial for controlling glucose excursions in healthy subjects. Patients with T2DM are characterized by an impaired capability to regulate their incretin effect, which may contribute to the exaggerated glucose excursions after oral ingestion of glucose in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is well-known that the incretin effect is weakened or no longer present in subjects with T2D, albeit more or less normal secretion of GIP e GLP-1 [16,17,18].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [17]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Self-citationReduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307 · cited 2×
“The incretin effect is gauged by comparing insulin responses after oral ingestion of glucose and isoglycemic iv glucose infusion (IIGI), respectively (6).”
BackgroundMethodTissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Cauter, E. V., Mestrez, F., Sturis, J., & Polonsky, K. S. (1992) · Diabetes · doi:10.2337/diab.41.3.368 · Cited by 890
Vilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
NAUCK, M. A., HOMBERGER, E., SIEGEL, E. G., ALLEN, R. C., EATON, R. P., EBERT, R., & CREUTZFELDT, W. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-2-492 · Cited by 874 · cited 6×
“(7) and us among healthy subjects are likely to result from deceleration of gastric emptying in response to the larger oral glucose loads as indicated by the acetaminophen results of the present study.”
BackgroundResultInfluentialDeterminants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients
Toft-Nielsen, M.-B., Damholt, M. B., Madsbad, S., Hilsted, L. M., Hughes, T. E., Michelsen, B. K., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7750 · Cited by 869
Research works printed but not linked: 3
- Willms, 1994, Inhibition of gastric emptying by glucagon-like peptide (7-36) amide in patients with type-2 diabetes mellitus., Diabetologia, 37, A118
- Knop, 2009, Glucagon responses to increasing oral loads of glucose and corresponding isoglycemic intravenous glucose infusions in patients with type 2 diabetes and healthy subjects., Diabetes, 58, A368
- Knop, 2008, Redcuced incretin effect in obese subjects with normal glucose tolerance as compared to lean control subjects., Diabetes, 57, A410
Cited by
Items 101–200 of 217
Doğruel, H., & Balcı, M. K. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i8.446 · Cited by 28
Chang, C.-Y., Kanthimathi, M. S., Tan, A. T. B., Nesaretnam, K., & Teng, K. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1307-9 · Cited by 27
Wu, J., Yu, H.-J., Lai, H., Yang, P., Lin, M., & Lai, F. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.09.011 · Cited by 24
Frost, F. J., Jones, G. H., Dyce, P., Jackson, V., Nazareth, D. S., & Walshaw, M. J. (2019) · Diabetic Medicine · doi:10.1111/dme.14121 · Cited by 25
Prevention of diabetes: a strategic approach for individual patients
Shin, J., Lee, J., Kim, H., Choi, Y., Cho, J., & Yoon, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2357 · Cited by 28
Wu, X., Li, Y., Wang, Q., Li, W., & Feng, Y. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.11.008 · Cited by 23
Grøndahl, M. F. G., Bagger, J. I., Lund, A., Faurschou, A., Rehfeld, J. F., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2018) · Diabetes Care · doi:10.2337/dc17-1818 · Cited by 26
Guiastrennec, B., Sonne, D. P., Hansen, M., Bagger, J. I., Lund, A., Rehfeld, J., Alskär, O., Karlsson, M., Vilsbøll, T., Knop, F. K., et al. (2016) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12152 · Cited by 22
Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes
Kamruzzaman, M., Horowitz, M., Jones, K. L., & Marathe, C. S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.661877 · Cited by 24
Liu, J., Zhang, D., Yang, Z., Hao, Y., Wang, Z., Wang, J., & Wang, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c04664 · Cited by 21
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysis
Grespan, E., Guolo, A., Muscelli, E., Ferrannini, E., & Mari, A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac213 · Cited by 26
Tura, A., Bagger, J. I., Ferrannini, E., Holst, J. J., Knop, F. K., Vilsbøll, T., & Mari, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.006 · Cited by 24
Grøndahl, M. F. G., Keating, D. J., Vilsbøll, T., & Knop, F. K. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0967-z · Cited by 23
Attenuated Postprandial GLP-1 Response in Parkinson’s Disease
Manfready, R. A., Engen, P. A., Verhagen Metman, L., Sanzo, G., Goetz, C. G., Hall, D. A., Forsyth, C. B., Raeisi, S., Voigt, R. M., & Keshavarzian, A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.660942 · Cited by 19
Alskär, O., Bagger, J. I., Røge, R. M., Knop, F. K., Karlsson, M. O., Vilsbøll, T., & Kjellsson, M. C. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.602 · Cited by 22
Meyer‐Gerspach, A. C., Cajacob, L., Riva, D., Herzog, R., Drewe, J., Beglinger, C., & Wölnerhanssen, B. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150803 · Cited by 19
Fujiwara, D., Takahashi, K., Suzuki, T., Shii, M., Nakashima, Y., Takekawa, S., Yoshida, A., & Matsuoka, T. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12103 · Cited by 18
Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes
Feng, R., Qian, C., Liu, Q., Jin, Y., Liu, L., Li, S., Liao, Y., Zhou, H., Liu, W., Rayner, C. K., et al. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.08.008 · Cited by 19
A perspective on the benefits of consumption of parboiled rice over brown rice for glycaemic control
Bhar, S., Bose, T., Dutta, A., & Mande, S. S. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02694-x · Cited by 20
Watkins, J. D., Carter, S., Atkinson, G., Koumanov, F., Betts, J. A., Holst, J. J., & Gonzalez, J. T. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155375 · Cited by 23
Innovative metabolic operations
COHEN, R. V., Caravatto, P. P. D. P., & Petry, T. B. Z. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.034 · Cited by 21
Stentz, F. B., Mikhael, A., Kineish, O., Christman, J. V., & Sands, C. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.11.027 · Cited by 28
Kim, M. K., Lee, H. H., Lee, S., Kwon, H., Baek, K., Kim, E. K., Lee, K. W., & Song, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2297 · Cited by 17
De Fano, M., Malara, M., Vermigli, C., & Murdolo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168650 · Cited by 17
Defining the role of GLP-1 receptor agonists for individualized treatment of Type 2 diabetes
Yabe, D., & Seino, Y. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.949672 · Cited by 16
Prévost, G., Arabo, A., Solliec, M.-A. L., Bons, J., Picot, M., Maucotel, J., Berrahmoune, H., Mehdi, M. E., Cherifi, S., Bénani, A., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2018 · Cited by 18
Mild diabetes: long‐term effects on gastric motility evaluated in rats
Hauschildt, A. T., Corá, L. A., Volpato, G. T., Sinzato, Y. K., Damasceno, D. C., & Américo, M. F. (2018) · International Journal of Experimental Pathology · doi:10.1111/iep.12262 · Cited by 18
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
Alicic, R. Z., Neumiller, J. J., & Tuttle, K. R. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01036-y · Cited by 22
Habib, H. A., Heeba, G. H., & Khalifa, M. M. A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119624 · Cited by 19
Giuseppe, G. D., Ciccarelli, G., CEFALO, C. M. A., Cinti, F., Moffa, S., Impronta, F., Capece, U., Pontecorvi, A., Giaccari, A., & Mezza, T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03405-9 · Cited by 17
Retinal vascular and structural dynamics during acute hyperglycaemia
Klefter, O. N., Vilsbøll, T., Knop, F. K., & Larsen, M. (2015) · Acta Ophthalmologica · doi:10.1111/aos.12797 · Cited by 15
Generation and application of avatars in pharmacometric modelling
Chasseloup, E., Hooker, A. C., & Karlsson, M. O. (2023) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-023-09873-9 · Cited by 13
van Olst, N., Meiring, S., de Brauw, M., Bergman, J. J. G. H. M., Nieuwdorp, M., van der Peet, D. L., & Gerdes, V. E. A. (2020) · Techniques and Innovations in Gastrointestinal Endoscopy · doi:10.1016/j.tige.2020.03.003 · Cited by 13
Perakakis, N., Kokkinos, A. D., Angelidi, A. M., Tsilingiris, D., Gavrieli, A., Yannakoulia, M., Tentolouris, N., & Mantzoros, C. S. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.07.001 · Cited by 13
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 15
Hammersjö, R., Roth, B., Höglund, P., & Ohlsson, B. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.79 · Cited by 14
Incretin-based therapy: a new horizon in diabetes management
Zarei, M., Vaighan, N. S., Farjoo, M. H., Talebi, S., & Zarei, M. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01479-3 · Cited by 13
The Gut: A Key to the Pathogenesis of Type 2 Diabetes?
Holst, J. J., Pedersen, J., Wewer Albrechtsen, N. J., & Knop, F. K. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0015 · Cited by 11
The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
Åhrén, B., Yamada, Y., & Seino, Y. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz036 · Cited by 12
Subramanian, V., Bagger, J. I., Harihar, V., Holst, J. J., Knop, F. K., & Villsbøll, T. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2023 · Cited by 12
Foghsgaard, S., Vedtofte, L., Mathiesen, E. R., Svare, J., Gluud, L. L., Holst, J. J., Damm, P., Knop, F. K., & Vilsbøll, T. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003834 · Cited by 13
Ruan, X., Zhang, W., Cai, H., Zheng, R., Jiang, F., & Zhu, H.-L. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.07.009 · Cited by 10
Yabe, D., Kuwata, H., Iwasaki, M., & Seino, Y. (2015) · EMJ Diabetes · doi:10.33590/emjdiabet/10312637 · Cited by 11
Treatment of type 2 diabetes in children: what are the specific considerations?
Grøndahl, M. F. G., Johannesen, J., Kristensen, K., & Knop, F. K. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1954160 · Cited by 13
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database
Cazzola, M., Matera, M. G., Calzetta, L., Lauro, D., & Rogliani, P. (2024) · Journal of Asthma · doi:10.1080/02770903.2024.2372600 · Cited by 14
Røge, R. M., Bagger, J. I., Alskär, O., Kristensen, N. R., Klim, S., Holst, J. J., Ingwersen, S. H., Karlsson, M. O., Knop, F. K., Vilsbøll, T., et al. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12792 · Cited by 9
Knop, F. K. (2018) · Endocrine Abstracts · doi:10.1530/endoabs.56.eje1 · Cited by 10
Gorini, F., & Tonacci, A. (2025) · Nutrients · doi:10.3390/nu17142350 · Cited by 11
Lauritzen, E. S., Støy, J., Bæch‐Laursen, C., Grarup, N., Jessen, N., Hansen, T. F., Møller, N., Hartmann, B., Holst, J. J., & Kampmann, U. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab521 · Cited by 11
Paternoster, S., Simpson, P. V., Kokh, E., Kizilkaya, H. S., ROSENKILDE, M. M., Mancera, R. L., Keating, D. J., Massi, M., & Falasca, M. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105822 · Cited by 8
A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment
Subramanian, V., Bagger, J. I., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.911616 · Cited by 10
Meeks, K. A. C., Bentley, A. R., Assimes, T. L., Franceschini, N., Adeyemo, A., Rotimi, C. N., & Doumatey, A. P. (2023) · Genome Medicine · doi:10.1186/s13073-023-01263-7 · Cited by 7
Niu, Y., Zhang, Q., & Wei, Y. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02254-9 · Cited by 7
Prévost, G., Ducrotte, P. R., Cailleux, A.-F., Khalfi, K., Basuyau, J. P., Lefèbvre, H., & Kuhn, J. M. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12150 · Cited by 7
Hasegawa, T., 駒形美穂, Hamasaki, A., Harada, N., Seino, Y., & Inagaki, N. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12896 · Cited by 7
Gastrointestinal Hormones Controlling Energy Homeostasis and Their Potential Role in Obesity
Andreoli, M. F., Francesco, P. N. D., & Perelló, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-89506-2_7 · Cited by 8
Assessment of the incretin effect in healthy subjects: concordance between clamp and OGTT methods
Aulinger, B. A., & D’Alessio, D. A. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00104.2022 · Cited by 6
The Potential Mechanism of Remission in Type 2 Diabetes Mellitus After Vertical Sleeve Gastrectomy
Wang, R., Mijiti, S., Xu, Q., Liu, Y., Deng, C., Huang, J., Yasheng, A., Tian, Y., Cao, Y., & Su, Y. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07378-z · Cited by 9
Traitement du diabète de type 2 : l’exénatide à libération prolongée
Guerci, B., & Sauvanet, J.-P. (2014) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(14)70734-5 · Cited by 6
The Dynamic Incretin Adaptation and Type 2 Diabetes
Åhrén, B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0299 · Cited by 6
Subramanian, V., Sherman, A., Holst, J. J., Knop, F. K., Vilsbøll, T., & Bagger, J. I. (2025) · Diabetologia · doi:10.1007/s00125-025-06524-1 · Cited by 6
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
Mathiesen, D. S., Bagger, J. I., Hansen, K. B., Junker, A. E., Plamboeck, A., Østoft, S. H., Idorn, T., Hornum, M., Holst, J. J., Jonsson, A. E., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0471 · Cited by 5
Bouzas, C., Pastor, R., García, S., Monserrat-Mesquida, M., Martínez‐González, M. Á., Salas‐Salvadó, J., Corella, D., Goday, A., Martínez, J. A., Alonso‐Gómez, Á. M., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114561 · Cited by 6
The clinical application of linagliptin in Asians
Zhou, Z., Cao, C., & Xiang, Y. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s64402 · Cited by 5
Oh, T. J., Park, K. S., & Cho, Y. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12623 · Cited by 6
In Vivo Models for Incretin Research: From the Intestine to the Whole Body
Oh, T. J. (2016) · Endocrinology and Metabolism · doi:10.3803/enm.2016.31.1.45 · Cited by 8
Fotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D. A., Holst, J. J., Vilsbøll, T., Knop, F. K., & Forbes, J. M. (2020) · Nutrients · doi:10.3390/nu12102928 · Cited by 6
Manell, E., Puuvuori, E., Svensson, A. C., Velikyan, I., Hulsart‐Billström, G., Hedenqvist, P., Holst, J. J., Jensen‐Waern, M., & Eriksson, O. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002083 · Cited by 11
Hædersdal, S., Lund, A., Nielsen-Hannerup, E., Maagensen, H., Forman, J. L., Holst, J. J., Knop, F. K., & Vilsbøll, T. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0291 · Cited by 6
PARKINSON, J. R., Hamrén, B., Kjellsson, M. C., & Skrtic, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13069 · Cited by 5
Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes
Park, S. H., Jung, M. H., Cho, W. K., Park, M. S., & Suh, B. (2015) · Clinical Endocrinology · doi:10.1111/cen.12802 · Cited by 5
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology
Frampton, R., HOCKING, S. L., SNAITH, J. R., & Greenfield, J. R. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.06.004 · Cited by 4
Mangliar, I. A., Plante, A.-S., Chabot, M., Savard, C., Lemieux, S., Michaud, A., Weisnagel, S. J., Lemyre, F. C., Veilleux, A., & Morisset, A. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0301 · Cited by 6
Bara, J. K., Gandhi, P., & Verma, P. K. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02398-8 · Cited by 8
Diabetes y osteoporosis: acción de las hormonas gastrointestinales sobre el hueso
García‐Martin, A., Reyes‐García, R., García-Castro, J. M., & Muñoz‐Torres, M. (2013) · Revista Clínica Española · doi:10.1016/j.rce.2013.01.014 · Cited by 7
Systems Pharmacology Modeling in Type 2 Diabetes Mellitus
Bosley, J., Maurer, T. S., & Musante, C. J. (2016) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-44534-2_20 · Cited by 4
Total synthesis and absolute structure of N55, a positive modulator of GLP-1 signaling
Lin, N.-P., & Chein, R. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/d0ob01722a · Cited by 4
Diabetes and osteoporosis: Action of gastrointestinal hormones on the bone
García‐Martin, A., Reyes‐García, R., García-Castro, J. M., & Muñoz‐Torres, M. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.05.004 · Cited by 6
Natali, A., Prato, S. D., & Mari, A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch8 · Cited by 6
Hamasaki, A., Harada, N., Muraoka, A., Yamane, S., Joo, E., Suzuki, K., & Inagaki, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1301352 · Cited by 3
Choi, K., Lee, J. C., Oh, T. J., Kim, M., Kim, H. C., Cho, Y. M., & Kim, S. (2015) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2015.2465156 · Cited by 3
Kim, S. H., Hur, K. Y., Chung, Y., & Kim, Y. J. (2020) · Daehan nae'si'gyeong bog'gang'gyeong oe'gwa haghoeji/Journal of minimally invasive surgery · doi:10.7602/jmis.2020.23.1.52 · Cited by 3
The Dose Effect of Whey Protein on Glycemic Control in Adults with Insulin Resistance
Castleberry, T. J., Irvine, C. J., Gordon, R. A., Brisebois, M. F., Deemer, S. E., Henderson, A., Sokoloski, M. L., & Ben‐Ezra, V. (2020) · International Journal of Food Science and Biotechnology · doi:10.11648/j.ijfsb.20200504.12 · Cited by 3
Barakat, G. M., Assi, G., Khalil, H., & Khatib, S. E. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998287178240403055901 · Cited by 3
Chan, W. B., Luk, A. O. Y., Chow, W. S., & Yeung, M. W. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12515 · Cited by 4
Suzuki, T., Takahashi, K., Fujiwara, D., Shii, M., Takekawa, S., & Matsuoka, T. (2015) · Diabetology International · doi:10.1007/s13340-015-0239-6 · Cited by 4
Incretin Based Therapies in Type 2 Diabetes Mellitus
Göksu, U. A., & Ünal, A. (2017) · Kafkas Journal of Medical Sciences · doi:10.5505/kjms.2017.94830 · Cited by 6
Glucose homeostasis and the gastrointestinal tract
Veedfald, S., Albrechtsen, N. J. W., & Holst, J. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-849886-6.00023-9 · Cited by 3
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD
Ahmadi, A., Gamboa, J. L., Norman, J., Enkhmaa, B., Tucker, M., Bennett, B. J., Zelnick, L. R., Fan, S., Berglund, L., Ikizler, T. A., et al. (2024) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000566 · Cited by 3
Vitamin K as an Endocrine Modulator: Mechanistic Links to Glucose Metabolism and Beyond
Matuszewski, W., Madeksza, M., Szklarz, M., Rutkiewicz, A., Rutkowska, J., & Harazny, J. M. (2026) · Nutrients · doi:10.3390/nu18081183 · Cited by 4
GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 Diabetes mit Fokus auf Tirzepatid
Nauck, M. A., Blüher, M., Meyhöfer, S. M., Heitmann, E., & Görgens, S. W. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-2102-2436 · Cited by 3
Bernsmeier, C., Meyer‐Gerspach, A. C., Blaser, L. S., Jeker, L., Steinert, R. E., Heim, M. H., & Beglinger, C. (2013) · Journal of Hepatology · doi:10.1016/s0168-8278(13)61317-3 · Cited by 2
Alicic, R. Z., & Neumiller, J. J. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2024.12.003 · Cited by 1
Winkler, G. (2011) · Orvosi Hetilap · doi:10.1556/oh.2011.29237 · Cited by 1
Kim, Y. G., & Cho, Y. M. (2013) · Journal of Korean Diabetes · doi:10.4093/jkd.2013.14.3.133 · Cited by 1
Effect of Bariatric Surgery on Incretin Function
Laferrère, B. (2015) · Springer eBooks · doi:10.1007/978-1-4939-3220-7_9 · Cited by 1
GLP-1 Isoforms for Diabetes-associated Cardiovascular Pathologies
Lorenzo, Ó. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000e110 · Cited by 1
39 Innovative Metabolic Operations
COHEN, R. V., Caravatto, P. P. D. P., & Petry, T. B. Z. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1637-5_39 · Cited by 1
Khiar, H., Lévêque, É., Lopez, A.-G., Moreau‐Grangé, L., Richard, L. M., Brunel, V., Perdrix, A., Takhlidjt, S., Devère, M., Tavolacci, M., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15871 · Cited by 1
Metadata
- Authors
- Bagger, J. I., Knop, F. K., Lund, A., Vestergaard, H., Holst, J. J., & Vilsbøll, T.
- Affiliations
- Herlev Hospital (DK)
- Gentofte Hospital (DK)
- University of Copenhagen (DK)
- Corresponding author
- Vilsbøll, Tina
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-03-01
- Volume
- 96
- Issue
- 3
- Pages
- 737-745
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2041551639
- Cited by
- 219
- References
- 33
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 15 · 2022: 8 · 2021: 14 · 2020: 15 · 2019: 18 · 2018: 11 · 2017: 14 · 2016: 25 · 2015: 17 · 2014: 14 · 2013: 23 · 2012: 10
- FWCI
- 14.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- incretin effect, type 2 diabetes, oral glucose tolerance test, glucose load, glycemic excursions, gastric emptying, glucose homeostasis
- MeSH terms
- Insulin Secretion, Acetaminophen, Adult, Aged, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Female, Gastric Emptying, Gastric Inhibitory Polypeptide, Glucose, Glucose Tolerance Test, Glycated Hemoglobin, Humans, Insulin, Male, Middle Aged, Analgesics, Non-Narcotic, Area Under Curve, Insulin-Secreting Cells, Glucagon-Like Peptide 1, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.